News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Pharmaron announced today that their Liverpool, UK based Gene Therapy CDMO has received a prestigious grant from the UK Government’s Life Sciences Innovation Manufacturing Fund (LSMIF) to ...

Program aimed to deliver early-stage clinical supply of plasmid DNA for drug substance manufacturing

Greater Manchester-based Seda Pharmaceutical Development Services reveals expansion plans following acquisition of new property. The firm is on track to double its staff and turnover in the ...

A new partnership between Lancaster University and biomedical firm ViraCorp has been launched to develop a unique nasal COVID-19 vaccine which attacks the virus at its entry point into the b...

A new programme of work led by the University of Liverpool is seeking to understand the very rare, but very serious, condition of blood clotting with low platelets in the general population,...

Researchers in Liverpool have begun recruiting patients to a ‘first-in-human’ clinical trial of personalised ‘vaccines’ that aim to reduce the risk of head and neck cancers – which...

Study will examine using different vaccines for the two doses, as well as different intervals between doses

Why biotech and pharmaceutical companies must spread their risk and keep their innovation programmes on track.

We all hope that a COVID-19 vaccine is on the horizon - but the global cold chain must be prepared to distribute these vaccines around the world.

While the world waits for a vaccine to be developed and approved for use against the COVID-19 virus, the best measure to identify, slow and prevent the spread of the virus is to test.

Providing large scale manufacturing capacity for AZD1222

Protect yourself from potential future legal issues once this crisis is over

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners